American Medical Association urges DHS to exempt physicians from new $100,000 H-1B visa fee

The American Medical Association and 53 medical societies have urged the Department of Homeland Security to exempt physicians from a new $100,000 H-1B visa application fee, arguing such foreign-trained professionals are vital for the U.S. healthcare workforce, especially in underserved regions. They contend the fee would exacerbate the projected physician shortage of up to 86,000 by 2036, negatively impacting patient access to care and increasing wait times.

Analysis

A coalition of 54 prominent U.S. medical societies, led by the American Medical Association, is actively lobbying the Department of Homeland Security against a proposed $100,000 application fee for H-1B visas for physicians. The core of their argument is that this policy would severely disrupt the healthcare labor supply chain, particularly for medically underserved and rural communities. According to advocacy groups, 64% of foreign-trained physicians in 2021 worked in such areas. The proposed fee introduces a significant regulatory and financial headwind for healthcare providers that rely on international medical graduates. This policy risk is amplified by the existing projection of a U.S. physician shortage of up to 86,000 by 2036, a gap the medical groups argue will widen if the fee is implemented, leading to reduced patient access and longer wait times. The moderately negative sentiment surrounding this news underscores the market's concern about potential operational strains and increased labor costs within the U.S. healthcare sector.

Key Decisions for Investors

• Investors with exposure to U.S. healthcare providers, particularly hospital operators and clinic networks in rural or designated shortage areas, should monitor the progression of this proposed H-1B fee as it poses a direct risk to labor costs and staffing stability.
• Consider evaluating the reliance of specific healthcare service companies on foreign-trained physicians; firms with lower dependency on H-1B visa holders may be better insulated from this specific regulatory headwind.
• This policy development represents a material political and regulatory risk for the healthcare sector, and its outcome could serve as a key indicator for future labor-related policies affecting the industry.